103
Participants
Start Date
March 15, 2021
Primary Completion Date
July 2, 2024
Study Completion Date
October 27, 2026
Atrasentan
Film-coated tablet
Novartis Investigative Site, St Leonards
Novartis Investigative Site, Gosford
Novartis Investigative Site, St Albans
Novartis Investigative Site, Reservoir
Novartis Investigative Site, Clayton
Novartis Investigative Site, Herston
Novartis Investigative Site, Anyang-si
Novartis Investigative Site, Lugo
Brookview Hills Research Assoc, Winston-Salem
Novartis Investigative Site, Madrid
Novartis Investigative Site, Majadahonda
Mountain Kidney And Hyper Associa, Asheville
Novartis Investigative Site, Port de Sagunt
Milwaukee Nephrologists SC, Wauwatosa
Uni of Minnesota Hos and Clinics, Minneapolis
Baylor Scott and White, Dallas
Prolato Clinical Research Center, Houston
Colorado Kidney Care, Denver
DaVita Clinical Research, Las Vegas
Academic Medical Research Institute, Los Angeles
Kidney Disease Medical Group, Glendale
North America Research Institute, San Dimas
Stanford U School Of Medicine, Stanford
Northwest Louisiana Nephrology Research, Shreveport
Tufts Medical Center, Boston
Novartis Investigative Site, Roma
Novartis Investigative Site, Cheonan
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Sheffield
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY